ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
Public ClinicalTrials.gov record NCT00350051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Study of ZK-Epothilone (ZK-Epo; ZK219477) Plus Prednisone as First-line Chemotherapy in Patients With Metastatic Androgen-independent Prostate Cancer
Study identification
- NCT ID
- NCT00350051
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Interventions
- Sagopilone (ZK 219477) + prednisone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Sep 23, 2008
- Completion
- Dec 20, 2009
- Last update posted
- Apr 7, 2021
2006 – 2009
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Sarasota | Florida | 34237 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Omaha | Nebraska | 68198-7680 | — |
| Not listed | The Bronx | New York | 10469 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Portland | Oregon | 97201 | — |
| Not listed | Altoona | Pennsylvania | 16601 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Seattle | Washington | 98108-1597 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00350051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2021 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00350051 live on ClinicalTrials.gov.